Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The

Keenan A Walker1, Melinda C Power2, Ron C Hoogeveen2

  • 1From the Department of Neurology (K.A.W., R.F.G.) and Department of Internal Medicine (E.S.), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health (M.C.P.); Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX (R.C.H., C.M.B.); Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, TX (R.C.H., C.M.B.); Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (A.R.F.); Department of Neurology (D.S.K.) and Department of Radiology (C.R.J.), Mayo Clinic, Rochester, MN; Department of Medicine, University of Mississippi Medical Center, Jackson (B.G.W.); and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (R.F.G., E.S.). kwalke26@jhmi.edu.

Stroke
|November 5, 2017
PubMed
Abstract

Insights

Midlife systemic inflammation, indicated by C-reactive protein (CRP), is linked to white matter abnormalities in older adults. This suggests inflammation may drive age-related brain changes and microangiopathy.

Area of Science:

  • Neurology
  • Gerontology
  • Inflammation Research

Background:

  • The link between midlife systemic inflammation and late-life brain abnormalities, including white matter (WM) changes and small vessel disease, remains unclear.
  • Systemic inflammation may play a role in the development of age-related neurological conditions.

Purpose of the Study:

  • To investigate the association between midlife systemic inflammation and late-life brain markers.
  • To examine how inflammation impacts white matter hyperintensity volume, microstructural integrity, cerebral infarcts, and microbleeds.

Main Methods:

  • Utilized data from the Atherosclerosis Risk in Communities Study, a biracial prospective cohort.
  • Employed linear and logistic regression to analyze the relationship between midlife high-sensitivity C-reactive protein (CRP) and brain MRI markers assessed 21 years later.
  • Included 1485 participants, adjusting for demographic factors and cardiovascular disease.

Main Results:

  • Increased midlife CRP levels were associated with reduced white matter microstructural integrity (lower fractional anisotropy, higher mean diffusivity) in deep and periventricular WM.
  • Stronger associations were observed between CRP and periventricular WM integrity in Black participants.
  • An association between higher CRP and white matter hyperintensity volume was noted in APOE ε4-positive individuals, extending to the entire sample after accounting for attrition.

Conclusions:

  • Midlife systemic inflammation may contribute to the development of chronic microangiopathic white matter abnormalities in older age.
  • Findings support the role of inflammation in promoting structural brain changes associated with aging and small vessel disease.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
590
Inflammation01:38

Inflammation

Overview
62.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646